Glass House Brands (GLAS) Other Working Capital Changes (2020 - 2026)
Glass House Brands' (GLAS) quarterly Other Working Capital Changes came in at $3.0 million in Q1 2026, up 4.55% year-on-year from $2.9 million in Q1 2025, and up 129.63% on a QoQ basis from -$10.2 million in Q4 2025.
Glass House Brands (GLAS) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Other Working Capital Changes data on file, last reported at $3.0 million in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 4.55% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 106.7% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 108.59% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $3.0 million, up from -$10.2 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for GLAS reached as high as $6.3 million in Q4 2024 and fell as low as -$7.5 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged $366742.0 across 5 years, with a median of $310000.0 in 2023.
- Across the five-year window, Other Working Capital Changes jumped 1611.69% in 2024 and plunged 1609.59% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at $116340.0 in 2022, then jumped by 870.37% to $1.1 million in 2023, then sank by 39.94% to $678000.0 in 2024, then plunged by 1609.59% to -$10.2 million in 2025, then jumped by 129.63% to $3.0 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $3.0 million in Q1 2026, -$10.2 million in Q4 2025, and $3.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Sep 30, 2025 | -2.69 Mn |
| Sep 30, 2025 | -2.69 Mn |
| Sep 30, 2025 | -2.69 Mn |
| Jun 30, 2025 | -243,000.00 |
| Jun 30, 2025 | -243,000.00 |
| Jun 30, 2025 | -243,000.00 |
| Mar 31, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Dec 31, 2024 | 6.33 Mn |
| Sep 30, 2024 | -1.94 Mn |
| Sep 30, 2024 | -1.94 Mn |